The Unrealized Potential of Cascade Testing
Genetics and Genomics
The latest headlines across every section, pulled from official and open-access sources.
Genetics and Genomics
Equity, Diversity, and Inclusion
This randomized clinical trial examines whether nasal continuous positive airway pressure (CPAP) is noninferior to nasal intermittent positive pressure ventilation (IPPV) as primary respiratory support for reducing intubation within 72 hours in preterm infants with respiratory distress syndrome.
This cohort study examines the association of initiated and sustained use of antidiabetic medications with risk for dementia, psychiatric emergency department use, or psychiatric hospitalization among older adults in the Veterans Affairs health care system.
This cross-sectional study of US adults assesses associations among barriers to healthy eating, sociodemographic characteristics, and health conditions driven by poor diet.
This cohort study evaluates the suitability of using social risk indices calculated with higher-level geographies and clinic addresses to measure patient-level exposures.
This case control study compares the odds of human papillomavirus (HPV)–related cancers in people with HIV and solid organ transplant recipients vs healthy controls and assesses how clinical and sociodemographic factors modify these associations.
This randomized clinical trial compares urinary tract infection incidence in patients aged 16 years or older using single-use vs reusable catheters in Dutch hospitals.
This cross-sectional study examines how often family members undergo cascade testing and evaluates demographic, socioeconomic, and clinical factors associated with this process
This cross-sectional study examines incidence trends of invasive breast cancer in Asian American, Native Hawaiian, and Pacific Islander females in the US.
June has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, the American Medical Association, CMS and R1 RCM named new executives. There were also layoffs at organizations including ADC Therapeutics, Equip and UPMC. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News .
New commissioner and extra funding announced to make maternity and neonatal care safer, fairer and more consistent across England.
Health tech companies made several major funding announcements in June. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in June appeared first on MedCity News .
PALSONIFY is a somatostatin receptor analog for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option.
FDA announces the selection of seven companies to participate in the FDA PreCheck Pilot Program, a new initiative designed to boost American global competitiveness, strengthen domestic drug manufacturing, and improve the resilience of the U.S. drug supply chain.
Ipsen is acquiring Kartos Therapeutics to get navtemadlin, which has reached Phase 3 testing in the blood cancer myelofibrosis. The Kartos oral small molecule takes a novel approach to restoring the function of p53, a tumor-suppressing protein. The post Ipsen’s $450M Deal Brings Drug That Could Make a Standard Blood Cancer Therapy Better appeared first on MedCity News .
BMA votes to accept offer that will see resident doctors benefit from new pay structure and better career-progression opportunities.
The Data Standards Strategy reinforces CDER’s ongoing commitment to the development, implementation, and maintenance of a comprehensive data standards program that will facilitate the efficient and effective review of regulatory submissions. This helps bring safe and effective products to market.
CDER Data Standards Program
Just two and a half months after buzzing out of stealth with $300 million and five autoimmune programs from Bristol Myers Squibb, busy Beeline Medicines has flown an extra $126.3 million back to its hive.
The ALONE-AF (Anticoagulation One Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation) trial examined whether discontinuing oral anticoagulation (OAC) in patients with elevated stroke risk after catheter ablation of atrial fibrillation (AFCA) who remain free of atrial arrhythmias in the year after their indexed ablation leads to fewer adverse clinical outcomes.
This episode is part of ACC’s ongoing initiative to recognize the risks and tackle management of Hypertriglyceridemia (HTG) and Severe Hypertriglyceridemia (sHTG).
The newly released AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (HF) addresses "changes in disease manifestations, diagnostic strategies and understanding of pathophysiology" and seeks to align terminology...
Innovative drugs often mean new treatment options for patients and advances in health care for the American public.